Diosmin

Generic Name
Diosmin
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C28H32O15
CAS Number
520-27-4
Unique Ingredient Identifier
7QM776WJ5N
Background

Chronic venous insufficiency is a common condition the western population. Compression and pharmacotherapy are frequently used to manage chronic venous insufficiency, improving circulation and symptoms of venous disease.
...

Indication

Diosmin is used over-the-counter alone or with ingredients such as hesperidin and diosmetin to support vein and capillary function.

Associated Conditions
Capillary fragility, Circulatory Function, Haemorrhoids, Venous Insufficiency, Healthy capillaries, Healthy veins
Associated Therapies
-

the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2023-07-12
Last Posted Date
2023-07-12
Lead Sponsor
Tanta University
Target Recruit Count
48
Registration Number
NCT05942547
Locations
🇪🇬

Tanta University, Tanta, Egypt

Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2023-01-04
Last Posted Date
2023-01-04
Lead Sponsor
Tanta University
Target Recruit Count
44
Registration Number
NCT05670457
Locations
🇪🇬

Tanta University, Tanta, El Gharbia, Egypt

the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2022-11-23
Last Posted Date
2023-04-12
Lead Sponsor
Tanta University
Target Recruit Count
60
Registration Number
NCT05626166
Locations
🇪🇬

Tanta university hospital, Tanta, Egypt

Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency

First Posted Date
2018-03-21
Last Posted Date
2018-06-20
Lead Sponsor
Fundação Educacional Serra dos Órgãos
Target Recruit Count
120
Registration Number
NCT03471910
Locations
🇧🇷

Centro Universitário Serra dos Órgãos - UNIFESO, Teresópolis, RJ, Brazil

Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis

First Posted Date
2018-01-29
Last Posted Date
2021-02-04
Lead Sponsor
Pirogov Russian National Research Medical University
Target Recruit Count
90
Registration Number
NCT03413618
Locations
🇷🇺

Clinical Hospital no.1 of the President's Administration of Russian Federation, Moscow, Russian Federation

Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD

Phase 1
Conditions
Interventions
First Posted Date
2015-11-30
Last Posted Date
2015-11-30
Lead Sponsor
Ain Shams University
Target Recruit Count
100
Registration Number
NCT02616731
Locations
🇪🇬

Ahmed Alanwar, Cairo, Egypt

Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-05-09
Last Posted Date
2016-02-02
Lead Sponsor
Benha University
Target Recruit Count
200
Registration Number
NCT02134249
Locations
🇪🇬

Benha univesity hospital, Benha, El Qualyobia, Egypt

🇪🇬

Banha Universty, Banha, El Qalubia, Egypt

Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs

First Posted Date
2012-02-15
Last Posted Date
2013-04-29
Lead Sponsor
Laboratoire Innotech International
Target Recruit Count
378
Registration Number
NCT01532882
Locations
🇫🇷

Dr Jean-Jérôme GUEX, Nice, France

© Copyright 2024. All Rights Reserved by MedPath